Sfoglia per Autore
Crosstalk between Nrf2 and YAP contributes to maintaining the antioxidant potential and chemoresistance in bladder cancer
2018-01-01 Ciamporcero, Eric; Daga, Martina; Pizzimenti, Stefania; Roetto, Antonella; Dianzani, Chiara; Compagnone, Alessandra; Palmieri, Antonietta; Ullio, Chiara; Cangemi, Luigi; Pili, Roberto; Barrera, Giuseppina
Application of an in house bioisosteric approach to the design of innovative inhibitors of aldo-keto reductase 1C3 (AKR1C3)
2019-01-01 Chiara Vigato, Agnese Chiara Pippione, Sandra Kovachka, Francesca Spyrakis, Martina Daga, Simonetta Oliaro Bosso, Marco Lucio Lolli, Donatella Boschi
Application of an in house bioisosteric approach to the design of innovative inhibitors of aldo-keto reductase 1C3 (AKR1C3)
2019-01-01 Chiara Vigato, Agnese Chiara Pippione, Sandra Kovachka, Francesca Spyrakis, Martina Daga, Simonetta Oliaro-Bosso, Marco Lucio Lolli, Donatella Boschi
Exploration of [2 + 2 + 2] cyclotrimerisation methodology to prepare tetrahydroisoquinoline-based compounds with potential aldo-keto reductase 1C3 target affinity
2019-01-01 Santos A.R.N.; Sheldrake H.M.; Ibrahim A.I.M.; Danta C.C.; Bonanni D.; Daga M.; Oliaro-Bosso S.; Boschi D.; Lolli M.L.; Pors K.
Post-translational inhibition of YAP oncogene expression by 4-hydroxynonenal in bladder cancer cells
2019-01-01 Cucci M.A.; Compagnone A.; Daga M.; Grattarola M.; Ullio C.; Roetto A.; Palmieri A.; Rosa A.C.; Argenziano M.; Cavalli R.; Simile M.M.; Pascale R.M.; Dianzani C.; Barrera G.; Pizzimenti S.
Effects of new hydroxyazoles inhibitors of AKR1C3 on vitality of prostate and colorectal cancer cell lines
2019-01-01 Valentina Boscaro, Donatella Boschi, Simonetta Oliaro-Bosso, Martina Daga, Marco Lolli, Agnese Chiara Pippione, Margherita Gallicchio
Novel tetrahydroacridine derivatives with iodobenzoic moieties induce G0/G1 cell cycle arrest and apoptosis in A549 non-small lung cancer and HT-29 colorectal cancer cells
2019-01-01 Girek M.; Klosinski K.; Grobelski B.; Pizzimenti S.; Cucci M.A.; Daga M.; Barrera G.; Pasieka Z.; Czarnecka K.; Szymanski P.
Ailanthone inhibits cell growth and migration of cisplatin resistant bladder cancer cells through down-regulation of Nrf2, YAP, and c-Myc expression
2019-01-01 Daga, Martina; Pizzimenti, Stefania*; Dianzani, Chiara; Cucci, Marie Angele; Cavalli, Roberta; Grattarola, Margherita; Ferrara, Benedetta; Scariot, Valentina; Trotta, Francesco; Barrera, Giuseppina
Glutathione-responsive cyclodextrin-nanosponges as drug delivery systems for doxorubicin: Evaluation of toxicity and transport mechanisms in the liver
2020-01-01 Daga M.; de Graaf I.A.M.; Argenziano M.; Barranco A.S.M.; Loeck M.; Al-Adwi Y.; Cucci M.A.; Caldera F.; Trotta F.; Barrera G.; Casini A.; Cavalli R.; Pizzimenti S.
Multiple catalytic activities of human 17β-hydroxysteroid dehydrogenase type 7 respond differently to inhibitors.
2020-01-01 Ferrante T, Adinolfi S, D'Arrigo G, Poirier D, Daga M, Lolli ML, Balliano G, Spyrakis F, Oliaro-Bosso S.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Crosstalk between Nrf2 and YAP contributes to maintaining the antioxidant potential and chemoresistance in bladder cancer | 2018 | Ciamporcero, Eric; Daga, Martina; Pizzimenti, Stefania; Roetto, Antonella; Dianzani, Chiara; Compagnone, Alessandra; Palmieri, Antonietta; Ullio, Chiara; Cangemi, Luigi; Pili, Roberto; Barrera, Giuseppina | |
| Application of an in house bioisosteric approach to the design of innovative inhibitors of aldo-keto reductase 1C3 (AKR1C3) | 2019 | Chiara Vigato, Agnese Chiara Pippione, Sandra Kovachka, Francesca Spyrakis, Martina Daga, Simonetta Oliaro Bosso, Marco Lucio Lolli, Donatella Boschi | |
| Application of an in house bioisosteric approach to the design of innovative inhibitors of aldo-keto reductase 1C3 (AKR1C3) | 2019 | Chiara Vigato, Agnese Chiara Pippione, Sandra Kovachka, Francesca Spyrakis, Martina Daga, Simonetta Oliaro-Bosso, Marco Lucio Lolli, Donatella Boschi | |
| Exploration of [2 + 2 + 2] cyclotrimerisation methodology to prepare tetrahydroisoquinoline-based compounds with potential aldo-keto reductase 1C3 target affinity | 2019 | Santos A.R.N.; Sheldrake H.M.; Ibrahim A.I.M.; Danta C.C.; Bonanni D.; Daga M.; Oliaro-Bosso S.; Boschi D.; Lolli M.L.; Pors K. | |
| Post-translational inhibition of YAP oncogene expression by 4-hydroxynonenal in bladder cancer cells | 2019 | Cucci M.A.; Compagnone A.; Daga M.; Grattarola M.; Ullio C.; Roetto A.; Palmieri A.; Rosa A.C.; Argenziano M.; Cavalli R.; Simile M.M.; Pascale R.M.; Dianzani C.; Barrera G.; Pizzimenti S. | |
| Effects of new hydroxyazoles inhibitors of AKR1C3 on vitality of prostate and colorectal cancer cell lines | 2019 | Valentina Boscaro, Donatella Boschi, Simonetta Oliaro-Bosso, Martina Daga, Marco Lolli, Agnese Chiara Pippione, Margherita Gallicchio | |
| Novel tetrahydroacridine derivatives with iodobenzoic moieties induce G0/G1 cell cycle arrest and apoptosis in A549 non-small lung cancer and HT-29 colorectal cancer cells | 2019 | Girek M.; Klosinski K.; Grobelski B.; Pizzimenti S.; Cucci M.A.; Daga M.; Barrera G.; Pasieka Z.; Czarnecka K.; Szymanski P. | |
| Ailanthone inhibits cell growth and migration of cisplatin resistant bladder cancer cells through down-regulation of Nrf2, YAP, and c-Myc expression | 2019 | Daga, Martina; Pizzimenti, Stefania*; Dianzani, Chiara; Cucci, Marie Angele; Cavalli, Roberta; Grattarola, Margherita; Ferrara, Benedetta; Scariot, Valentina; Trotta, Francesco; Barrera, Giuseppina | |
| Glutathione-responsive cyclodextrin-nanosponges as drug delivery systems for doxorubicin: Evaluation of toxicity and transport mechanisms in the liver | 2020 | Daga M.; de Graaf I.A.M.; Argenziano M.; Barranco A.S.M.; Loeck M.; Al-Adwi Y.; Cucci M.A.; Caldera F.; Trotta F.; Barrera G.; Casini A.; Cavalli R.; Pizzimenti S. | |
| Multiple catalytic activities of human 17β-hydroxysteroid dehydrogenase type 7 respond differently to inhibitors. | 2020 | Ferrante T, Adinolfi S, D'Arrigo G, Poirier D, Daga M, Lolli ML, Balliano G, Spyrakis F, Oliaro-Bosso S. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile